
Upper zzso deep vein zzso zzso is now recognized as a major cause of morbidity and zzso There is little information regarding the most effective treatment of this zzso We report a prospective cohort study of the use of low molecular weight zzso zzso in the zzso management of upper zzso zzso zzso patients were managed as zzso for zzso documented upper zzso zzso with zzso zzso zzso zzso for a minimum of five zzso zzso was usually initiated on the first day with a target zzso of zzso Most patients had an underlying zzso or a history of a central zzso All patients were followed for 12 weeks from zzso Only one patient had a major zzso No patients developed pulmonary zzso One patient had a recurrence of zzso during the treatment with zzso with extension of the existing zzso Seven patients died, all due to their underlying zzso This study supports the safety and effectiveness of zzso in the treatment of upper zzso zzso Given that these patients were treated as zzso there is a potential for huge cost zzso 

